Healthcare
Sino Biopharma records $1,852m revenue in H1
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
IHH Healthcare acquires Prince Court Medical Centre in Kuala Lumpur
It became the 16th hospital under the group in Malaysia.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.
Thomson Medical to roll out secure messaging platform
The end-to-end encryption system is expected to protect patient data privacy.
Bumrungrad International Hospital creates first digital microbiology laboratories.
This includes the digitization of its core laboratory, handling 60-70% of its annual tests.
COVID-19 dampens Japan's pharma market
Reduced healthcare spending will affect multinationals' capabilities to launch new products.
Malaysia's ageing population to drive healthcare demand
The country is having high incidence and prevalence of non-communicable diseases.
COVID-19 pushes healthcare sector reform in Pakistan
Poor track record may delay the process despite the government's political will.
Australia healthcare spending signals future growth
High demand is forecasted in the pharmaceuticals industry.
Pandemic to further ramp up healthcare spending in APAC
Countries are declaring fiscal stimulus packages to fight the pandemic.
Viva Biotech buys 80% share of Langhua Pharma
The company expects to deliver more comprehensive end-to-end services through this acquisition.
China's healthcare spending to reach $49b by 2023
By then, China will account for 23% of the world’s healthcare spending.
COVID-19 jumpstarts Indonesia's telehealth industry
The government has quickly made digital health platforms available to address the pandemic.
Telemedicine on the rise in South Korea despite legal barriers
COVID-19 has forced the government to speed up the regulatort infrastructure around telemedicine initiatives.
UG Healthcare hits record net profit of $13.4m in FY20
The company is set to pay 0.714 cents dividend per ordinary share.
Private operator Healthscope sells New Zealand pathology business for $364m
Customary approval is expected to be completed within the next six months.
Pharma export trajectory to further improve in Bangladesh
The government aims to raise self-sufficiency in key pharmaceutical raw materials.